KalVista Pharmaceuticals creating a new generation of small molecule protease inhibitors for HAE and DME Hereditary Angioedema (HAE)Diabetic Macular Edema (DME)
News KalVista Pharmaceuticals to Present at Upcoming Investor Conferences Nov 9, 2020 KalVista Pharmaceuticals Provides Update on Oral Hereditary Angioedema Franchise Oct 15, 2020 KalVista Pharmaceuticals Reports First Fiscal Quarter Results Sep 14, 2020 All News
